Uncategorized
Ocular Therapeutix™ to Present at Two Upcoming Investor Conferences
BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Amar Sawhney, Ph.D., President and Chief Executive Officer, will present at two upcoming investor conferences: Stifel 2016 Healthcare ConferenceTuesday, November 15, 2016 at 10:15 a.m. Eastern TimeLotte New York Palace Hotel, New York, NY Piper Jaffray 28th Annual
